Core Viewpoint - The chairman of MicroTech Medical (02235.HK), Zheng Pan, has reduced his stake by selling 2.09 million shares at a price of HKD 6.9 per share, totaling HKD 14.42 million, resulting in a new holding of approximately 38.70 million shares, representing 22.88% of the company [1][1][1]. Group 1: Shareholder Activity - Zheng Pan sold 2.09 million shares of MicroTech Medical at HKD 6.9 each, amounting to HKD 14.42 million [1][1][1]. - After the sale, his remaining shares are approximately 38.70 million, which is 22.88% of the total shares [1][1][1]. Group 2: Stock Performance - As of November 24, 2025, MicroTech Medical-B closed at HKD 6.8, unchanged from the previous trading day, with a trading volume of 79,500 shares and a turnover of HKD 532,700 [1][1][1]. - The stock has received a "Buy" rating from one investment bank in the last 90 days [1][1][1]. Group 3: Company Metrics - MicroTech Medical-B has a market capitalization of HKD 1.132 billion, ranking 21st in the medical device II industry [1][1][1]. - Key performance indicators include: - ROE: -1.36% (industry average: -4.03%, rank: 20) [1][1][1] - Market capitalization: HKD 1.132 billion (industry average: HKD 4.94 billion, rank: 21) [1][1][1] - Revenue: HKD 441 million (industry average: HKD 1.195 billion, rank: 18) [1][1][1] - Net profit margin: -0.93% (industry average: -16.5%, rank: 18) [1][1][1] - Gross profit margin: 51.66% (industry average: 54.89%, rank: 18) [1][1][1] - Debt ratio: 10.8% (industry average: 29.03%, rank: 5) [1][1][1].
董事会主席郑攀减持微泰医疗(02235.HK)209万股 每股作价6.9港元